The general landscape of XBP1 and immune checkpoint alteration in ovarian cancer was compactly visualized, including amplification, deep deletion, fusion, structural variant, truncating, missense, and splice mutations (Figure 2A). This evidence concerns the gene XBP1 and ovarian carcinoma.